In conclusion, our current study demonstrated that reducing Nm23H1 in ESCC cells may inactivate the AKT signaling pathway and downregulate CLDN1 expression, thereby increase the invasiveness of ESCC cells. This evidence concerns the gene CLDN1 and esophageal squamous cell carcinoma.